Humana's acquisition of Coronaria Hoiva approved by the competition authority

Humana's acquisition of Finnish Coronaria Hoiva has been approved by the Finnish Competition and Consumer Authority, KKV.

As previously announced, see press release as of January 28, 2019, Humana has entered into an agreement to acquire all the shares in Finnish Coronaria Hoiva Oy, one of the leading care providers in Finland. The acquisition has today been approved by the Finnish Competition and Consumer Authority, KKV.

The approval does not require any special conditions or concessions from Humana's side.

Coronaria Hoiva is expected to be consolidated in Humana's accounts during April 2019.

For more information, please contact:
Ulf Bonnevier, CFO, +46 70 164 73 17, ulf.bonnevier@humana.se
Anna Sönne, Head of Investor Relations, +46 70 601 48 53, anna.sonne@humana.se

Humana is a leading Nordic care company providing services within individual and family care, personal assistance, elderly care and special service housing in accordance with LSS. Humana has some 15,000 employees in Sweden, Norway, Finland and Denmark providing care for over 8,000 individuals and working to achieve the vision “Everyone is entitled to a good life”. In 2018, Humana’s operating revenue was SEK 6,725 M. Humana is listed on Nasdaq Stockholm since 2016 and company’s headquarters are located in Stockholm. Read more about Humana on: www.humana.se or corporate.humana.se/en

Tags: